- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: AZD9291
Total 241 results
-
National Cancer Institute (NCI)Active, not recruitingAcute Myeloid Leukemia | Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Myelodysplastic Syndrome | Acute Myeloid Leukemia Post Cytotoxic TherapyUnited States
-
Guangdong Association of Clinical TrialsNot yet recruiting
-
M.D. Anderson Cancer CenterCompletedStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Recurrent Lung Non-Small Cell CarcinomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal CarcinomaUnited States
-
AstraZenecaActive, not recruitingSolid TumorsBelgium, United Kingdom, Switzerland, Australia
-
AstraZenecaBritish Columbia Cancer AgencyCompleted
-
AstraZenecaRecruitingNon-Small Cell Lung CancerChina, United States, Chile, Vietnam, Thailand, Brazil, Bulgaria, Canada, Germany, India, Japan, Korea, Republic of, Poland, Russian Federation, Singapore, Turkey, Austria, Israel, Spain, Taiwan, Mexico, France, Italy, Peru, Switzerland, United...
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Advanced Lung Non-Squamous Non-Small Cell Carcinoma | Metastatic Lung Non-Squamous Non-Small Cell Carcinoma and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); National Comprehensive Cancer NetworkActive, not recruitingStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Lung Non-Small Cell Carcinoma | Stage IV Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Recurrent Lung Non-Small Cell CarcinomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Lung Non-Small Cell Carcinoma | Stage IIIA Lung Non-Small Cell Cancer AJCC v7 | Recurrent Lung Non-Small Cell Carcinoma | Stage IIIB Lung Non-Small Cell Cancer AJCC v7 | Stage IV Lung Non-Small Cell Cancer AJCC v7 | Stage III Lung Non-Small Cell Cancer AJCC v7United States, Canada
-
Taizhou HospitalNot yet recruitingLung Cancer, Nonsmall Cell
-
Institute of Cancer Research, United KingdomRoyal Marsden NHS Foundation TrustUnknownAdenocarcinoma of the ProstateUnited Kingdom
-
AstraZenecaKuDOS Pharmaceuticals LimitedCompleted
-
Memorial Sloan Kettering Cancer CenterAstraZeneca; Genentech, Inc.CompletedNon-small Cell Lung Cancer | EGFR-mutant Lung CancersUnited States
-
FibroGenAstraZeneca; Astellas Pharma Europe B.V.CompletedAnemia in Incident Dialysis PatientsRussian Federation, Bulgaria, Thailand, United States, Argentina, Chile, Colombia, Korea, Republic of, Latvia, Malaysia, Mexico, Poland, Romania, Taiwan, Ukraine
-
MedSIRTerminated
-
Nilratan Sircar Medical CollegeRecruiting
-
Beth Israel Deaconess Medical CenterJohns Hopkins University; Dana-Farber Cancer Institute; AstraZenecaActive, not recruitingMetastatic Breast Cancer | Invasive Breast Cancer | BRIP1 Gene Mutation | PALB2 Gene Mutation | ATM Gene Mutation | CHEK2 Gene Mutation | NBN Gene Mutation | RAD51 Gene Mutation | Somatic Mutation Breast Cancer (BRCA1) | Somatic Mutation Breast Cancer (BRCA2)United States
-
AstraZenecaKuDOS Pharmaceuticals LimitedCompletedBreast NeoplasmsSweden, United States, United Kingdom, Germany, Spain, Australia, Israel, Canada
-
University of Michigan Rogel Cancer CenterActive, not recruitingProstate CancerUnited States
-
FibroGenAstraZeneca; Astellas Pharma Europe B.V.CompletedCKD AnemiaUnited States, Australia, Thailand, Korea, Republic of, Malaysia, Mexico, Taiwan, New Zealand, Argentina, Chile, Colombia, Hong Kong, Peru, Philippines, Puerto Rico, Singapore
-
Royal Marsden NHS Foundation TrustAstraZeneca; Institute of Cancer Research, United KingdomCompleted
-
Lisette NixonAstraZenecaUnknownNon-small Cell Lung CancerUnited Kingdom
-
AstraZenecaCompletedAdvanced Solid TumorsUnited States, Spain
-
The Netherlands Cancer InstituteAstraZenecaActive, not recruitingHead and Neck Neoplasms | Carcinoma, Squamous Cell | Laryngeal Cancer Stage II | Laryngeal Cancer Stage IIINetherlands
-
Thomas Jefferson UniversityAstraZenecaActive, not recruitingRecurrent Breast Carcinoma | Metastatic Malignant Neoplasm in the Chest WallUnited States
-
AstraZenecaRecruitingCarcinoma | Non-Small-Cell LungChina, Israel, Spain, United States, Canada, Italy, Korea, Republic of, Belgium, Bulgaria, Vietnam, Japan, United Kingdom, Brazil, France, Philippines, Taiwan, Thailand, Germany, Poland, Austria, Greece, Turkey, Argentina, Hong Kong, Chile and more
-
Dana-Farber Cancer InstituteWithdrawnOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States
-
AstraZenecaCompletedHead and Neck Squamous Cell CarcinomaTaiwan, United States, France
-
Cambridge University Hospitals NHS Foundation TrustAstraZenecaCompletedProstate CancerUnited Kingdom
-
National Cancer Institute (NCI)RecruitingRecurrent Ovarian High Grade Serous Adenocarcinoma | Recurrent Platinum-Resistant Ovarian CarcinomaUnited States
-
Istituto Scientifico Romagnolo per lo Studio e...UnknownNeoplasms, Germ Cell and EmbryonalItaly
-
Luca RonfaniUniversity of TriesteCompletedUrea Cycle Disorders, Inborn | Other Metabolic DiseasesItaly
-
AstraZenecaCompletedOvarian Neoplasms | BRCA1 Protein | BRCA2 ProteinNetherlands, Belgium, United Kingdom, Poland
-
AstraZenecaKuDOS Pharmaceuticals LimitedCompletedOvarian NeoplasmUnited States, Spain, Australia, Germany, Sweden
-
AstraZenecaDaiichi SankyoNot yet recruiting
-
AstraZenecaCompleted
-
Merck Sharp & Dohme LLCAstraZenecaRecruitingAdvanced Solid NeoplasmsUnited States, Argentina, Australia, Canada, Colombia, Denmark, France, Guatemala, Ireland, Israel, Japan, Korea, Republic of, Mexico, Peru, Romania, Russian Federation, Spain, Switzerland, Turkey, United Kingdom, Italy
-
CSL BehringParexelCompletedHereditary Angioedema Types I and IIUnited States, Germany
-
Second Affiliated Hospital of Nanchang UniversityNanchang UniversityUnknownNon-small Cell Lung Cancer | EGFR Activating Mutation | Leptomeningeal Metastasis
-
National Cancer Institute (NCI)RecruitingBreast Inflammatory CarcinomaUnited States, Canada, Puerto Rico
-
The Netherlands Cancer InstituteCompletedLocally Advanced Malignant Neoplasm | Triple-Negative Invasive Breast Carcinoma | Inflammatory Breast CarcinomaNetherlands
-
The Netherlands Cancer InstituteAstraZenecaCompleted
-
AstraZenecaEli Lilly and CompanyCompletedHealthyUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Stage IIIC Lung Cancer AJCC v8 | Unresectable Lung Non-Small Cell Carcinoma | Advanced Lung Non-Small Cell... and other conditionsUnited States
-
AstraZenecaCompletedOvarian CancerCanada, Czechia, Poland, Romania, United States, Belgium, France, Russian Federation, United Kingdom, Israel, Spain, Germany, Austria, Netherlands, Australia, Estonia, Ukraine
-
University of Colorado, DenverCompletedSquamous Cell Carcinoma of the Head and NeckUnited States
-
OHSU Knight Cancer InstituteOregon Health and Science University; Prospect Creek FoundationCompletedAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast CarcinomaUnited States
-
Joseph Paul EderDana-Farber Cancer Institute; The Cleveland Clinic; Vanderbilt-Ingram Cancer...Terminated
-
AstraZenecaParexelWithdrawnOvarian CancerUnited States, Italy, Canada, Spain